Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

T-bet Transcendent: Unmasking the Faces of Multifarious Immunity

Steven L. Reiner
J Immunol April 1, 2015, 194 (7) 2959-2960; DOI: https://doi.org/10.4049/jimmunol.1500289
Steven L. Reiner
Department of Microbiology and Immunology and Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, NY 10032
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

We dwell in an environment filled with germs of different sizes and lifestyles. In response, we have evolved a sophisticated system of host defense that can recognize nearly limitless antigenic shapes. We have also evolved the flexibility to combat the different evasion mechanisms of intruders with a suitably strategic counteroffensive. The way we eliminate intracellular pathogens, viruses, and cancer cells (type 1 immunity) is distinct from how we reject intestinal worms (type 2 immunity) or how we neutralize extracellular bacteria (type 17 or type 3 immunity). The Pillars of Immunology article featured in this issue by Szabo et al. (1) provided crucial insight into how a naive CD4+ T cell begets a distinct lineage of effector cells and, in so doing, identified the key transcription factor of type 1 immunity.

Understanding how we develop and deploy different forms of attack against microbes was a major preoccupation for contemporary immunology at the end of the 20th century. It was understood that humoral immunity and cell-mediated immunity were distinct and sometimes complementary immune functions (2). Investigation into the nature of the immune response decision turned toward the field of Th cell subset heterogeneity after the discovery that cloned, Ag-specific CD4+ T cells segregated into mutually exclusive patterns of helper function and cytokine secretion (3). The lynchpin of type 1 defense, CD4+ Th1 cells are capable of secreting IFN-γ, which, among other functions, instructs cells harboring an intracellular infection to produce reactive oxygen and nitrogen species that could eliminate their unwanted invasion.

The landmark study from Laurie Glimcher’s laboratory reported cloning and characterization of the master transcription factor of Th1 cells (1). The authors named the novel member of the T-box–containing transcription factor family “T-bet,” for T-box factor expressed in T cells. The effort, which has been recounted in an entertaining narrative by Dr. Glimcher (4), was spearheaded by a talented postdoctoral fellow, Susanne Szabo, who had studied IL-12 signaling in Th1 cells while she was a graduate student in Ken Murphy’s laboratory at Washington University.

From the early days of studying cloned CD4+ T cells (3), IL-2 was thought to be a Th1-specific cytokine, although now it is typically associated with naive and central memory T cells. The strategy employed by Szabo, Glimcher, and colleagues was to find factors that could transactivate the Il2 promoter, which T-bet apparently could do in the context of the yeast one-hybrid screen (1). When studied in the context of actual T cells, T-bet was later shown to be a repressor of Il2. Importantly, when genetically introduced into CD4+ T cells, T-bet was capable of inducing abundant expression of IFN-γ, the signature of Th1 cells, and repressing expression of IL-4, the signature of Th2 cells.

During the ensuing years, genetic, biochemical, and cell biological studies from the Glimcher laboratory and their collaborators have only amplified the importance of T-bet as the key upstream transcription factor of Th1 cells (5). T-bet imparts a Th1-specific gene expression program while repressing Th2 and Th17 genes. T-bet acts as a conventional transcriptional activator of some genes and a remodeler of heritable chromatin structure at other loci. T-bet informs Th1 cells on actions as wide-ranging as cytokine synthesis, tissue localization, restricted growth factor consumption, and terminal senescence.

Prior to the identification of T-bet, Th1 and Th2 differentiation was a problem largely understood as the sum of the cytokine signaling received by a naive T cell. The discoveries of T-bet (1) along with that of Gata-3 (6) and later retinoic acid–related orphan receptor γt (7) as the key upstream transcription factors of Th1, Th2, and Th17 cells, respectively, have been critical pieces of the puzzle for deciphering the signaling and transcriptional networks of T cell differentiation during the immune response. The identification of T-bet was a watershed moment for the field to begin understanding the issues of plasticity, flexibility, heritability, and reversibility of the distinct cell fates that are carved out of a common naive precursor.

The cloning and characterization of T-bet as the key transcription factor of CD4+ Th1 cells paved numerous other important paths of discovery (5). Subsequent findings by Dr. Glimcher’s laboratory and those of her colleagues concerning the roles of T-bet across numerous hematopoietic lineages helped solidify T-bet’s role as a key regulator of almost every facet of type 1 immunity. T-bet also plays critical roles in the development and/or function of CD8+ T cells, atypical T cell subsets, innate lymphoid cells (including NK cells), dendritic cells, and B cells. Not surprisingly, T-bet has been implicated in the pathogenesis of infectious, autoimmune, inflammatory, and neoplastic processes (5).

T-bet’s representation as the molecular signature of type 1 immune cells has been a beacon in the fog that helped lead us forward. Without T-bet, it seems unlikely we would have arrived at our current understanding of the modular nature of immune function and the appreciation that distinct modules transcend numerous interacting cell types (8–11). Like many great discoveries, the identification of T-bet as the key transcriptional regulator of Th1 cells continues to be an enduring gift to the field in many unexpected ways.

Disclosures

The author has no financial conflicts of interest.

Acknowledgments

I am grateful to Dr. Pamela Fink for choosing the T-bet paper to be highlighted in Pillars of Immunology and for asking me to write about it.

  • Copyright © 2015 by The American Association of Immunologists, Inc.

References

  1. ↵
    1. Szabo S. J.,
    2. S. T. Kim,
    3. G. L. Costa,
    4. X. Zhang,
    5. C. G. Fathman,
    6. L. H. Glimcher
    . 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655–669.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Parish C. R.,
    2. F. Y. Liew
    . 1972. Immune response to chemically modified flagellin. 3. Enhanced cell-mediated immunity during high and low zone antibody tolerance to flagellin. J. Exp. Med. 135: 298–311.
    OpenUrlAbstract
  3. ↵
    1. Mosmann T. R.,
    2. H. Cherwinski,
    3. M. W. Bond,
    4. M. A. Giedlin,
    5. R. L. Coffman
    . 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136: 2348–2357.
    OpenUrlAbstract
  4. ↵
    1. Glimcher L. H.
    2007. Trawling for treasure: tales of T-bet. Nat. Immunol. 8: 448–450.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Lazarevic V.,
    2. L. H. Glimcher,
    3. G. M. Lord
    . 2013. T-bet: a bridge between innate and adaptive immunity. Nat. Rev. Immunol. 13: 777–789.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Zheng W.,
    2. R. A. Flavell
    . 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89: 587–596.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Ivanov I. I.,
    2. B. S. McKenzie,
    3. L. Zhou,
    4. C. E. Tadokoro,
    5. A. Lepelley,
    6. J. J. Lafaille,
    7. D. J. Cua,
    8. D. R. Littman
    . 2006. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121–1133.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Medzhitov R.
    2007. Recognition of microorganisms and activation of the immune response. Nature 449: 819–826.
    OpenUrlCrossRefPubMed
    1. Sallusto F.,
    2. A. Lanzavecchia
    . 2009. Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity. Eur. J. Immunol. 39: 2076–2082.
    OpenUrlCrossRefPubMed
    1. Gasteiger G.,
    2. A. Y. Rudensky
    . 2014. Interactions between innate and adaptive lymphocytes. Nat. Rev. Immunol. 14: 631–639.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Artis D.,
    2. H. Spits
    . 2015. The biology of innate lymphoid cells. Nature 517: 293–301.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Journal of Immunology: 194 (7)
The Journal of Immunology
Vol. 194, Issue 7
1 Apr 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Advertising (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
T-bet Transcendent: Unmasking the Faces of Multifarious Immunity
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
T-bet Transcendent: Unmasking the Faces of Multifarious Immunity
Steven L. Reiner
The Journal of Immunology April 1, 2015, 194 (7) 2959-2960; DOI: 10.4049/jimmunol.1500289

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
T-bet Transcendent: Unmasking the Faces of Multifarious Immunity
Steven L. Reiner
The Journal of Immunology April 1, 2015, 194 (7) 2959-2960; DOI: 10.4049/jimmunol.1500289
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Disclosures
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Conceiving the Inconceivable: The Function of Aire in Immune Tolerance to Peripheral Tissue-Restricted Antigens in the Thymus
  • Glial Cells as Regulators of Neuroimmune Interactions in the Central Nervous System
  • The Colon as a Major Site of Immunoregulation by CD4+ T Cell Subsets in the Steady State
Show more PILLARS OF IMMUNOLOGY

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606